3-piperidinylisochroman-5-ols as dopamine agonists
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Apr 5, 2011
Grant Date -
May 3, 2007
app pub date -
Oct 24, 2006
filing date -
Apr 29, 2004
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
The present invention provides compounds of formula I:, X and n are defined as defined herein. Additionally, a method for treating dopamine-related neurological disorders selected form the group consisting of neurological, psychological, cardiovascular, cognitive or attention disorders, substance abuse and addictive behavior, or a combination thereof, comprising administering to a patient in need of such treatment a therapeutically effective amount of compounds of formula I.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully